Figure 2.

Quotients of CSF mononuclear cells and CSF CXCL13 before and after treatment. Quotients are calculated as (CSF mononuclear cells before treatment)/(CSF mononuclear cells after treatment) and (CSF CXCL13 before treatment)/(CSF CXCL13 after treatment). Spearman rā€‰=ā€‰0.37, Pā€‰=ā€‰0.036.

Bremell et al. BMC Neurology 2013 13:2   doi:10.1186/1471-2377-13-2
Download authors' original image